AU2013338705B2 - Synbiotics combination for brain improvement - Google Patents

Synbiotics combination for brain improvement Download PDF

Info

Publication number
AU2013338705B2
AU2013338705B2 AU2013338705A AU2013338705A AU2013338705B2 AU 2013338705 B2 AU2013338705 B2 AU 2013338705B2 AU 2013338705 A AU2013338705 A AU 2013338705A AU 2013338705 A AU2013338705 A AU 2013338705A AU 2013338705 B2 AU2013338705 B2 AU 2013338705B2
Authority
AU
Australia
Prior art keywords
oligosaccharides
glutamine
decreased
infants
infant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013338705A
Other languages
English (en)
Other versions
AU2013338705A2 (en
AU2013338705A1 (en
Inventor
Nana BARTKE
Johan Garssen
Aletta Desiree Kraneveld
Ruurd VAN ELBURG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia NV filed Critical Nutricia NV
Publication of AU2013338705A2 publication Critical patent/AU2013338705A2/en
Publication of AU2013338705A1 publication Critical patent/AU2013338705A1/en
Application granted granted Critical
Publication of AU2013338705B2 publication Critical patent/AU2013338705B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2013338705A 2012-11-02 2013-11-04 Synbiotics combination for brain improvement Active AU2013338705B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261721833P 2012-11-02 2012-11-02
EP12191171.3 2012-11-02
US61/721,833 2012-11-02
EP12191171 2012-11-02
PCT/NL2013/050785 WO2014070016A2 (en) 2012-11-02 2013-11-04 Synbiotics combination for brain improvement

Publications (3)

Publication Number Publication Date
AU2013338705A2 AU2013338705A2 (en) 2015-06-04
AU2013338705A1 AU2013338705A1 (en) 2015-06-04
AU2013338705B2 true AU2013338705B2 (en) 2017-06-15

Family

ID=47148641

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013338705A Active AU2013338705B2 (en) 2012-11-02 2013-11-04 Synbiotics combination for brain improvement

Country Status (12)

Country Link
US (2) US9974816B2 (enExample)
EP (2) EP2914136B1 (enExample)
CN (2) CN107853705A (enExample)
AU (1) AU2013338705B2 (enExample)
BR (1) BR112015009579B1 (enExample)
ES (1) ES2884223T3 (enExample)
IN (1) IN2015DN03862A (enExample)
MY (1) MY173726A (enExample)
PH (1) PH12015500904B1 (enExample)
PL (1) PL2914136T3 (enExample)
RU (1) RU2630905C2 (enExample)
WO (1) WO2014070016A2 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015160234A1 (en) * 2014-04-17 2015-10-22 N.V. Nutricia Composition for brain improvement
US20150305359A1 (en) * 2014-04-24 2015-10-29 Mead Johnson Nutrition Company Nutritional compositions directed to subjects having cow's milk protein allergies
WO2016013928A1 (en) * 2014-07-24 2016-01-28 N.V. Nutricia Prevention or treatment of food allergy in infants and toddlers
WO2016043583A1 (en) * 2014-09-15 2016-03-24 N.V. Nutricia Reducing anxiety in progeny
RU2761533C2 (ru) * 2014-09-25 2021-12-09 Сосьете Де Продюи Нестле С.А. Система детской смеси с адаптивными концентрациями олигосахаридов грудного молока (огм)
WO2016086157A1 (en) * 2014-11-26 2016-06-02 Abbott Laboratories Infant formula comprising human milk oligosaccharides, polyunsaturated fatty acids, nucleotides, and lutein
CN108348493B (zh) 2015-10-02 2022-03-29 荷兰纽迪希亚公司 甘氨酸用于过敏性患者的耐受性诱导
PT3389404T (pt) 2015-12-15 2020-01-14 Nestle Sa Mistura de hmos
US10925906B2 (en) * 2016-04-13 2021-02-23 Meiji Co., Ltd. Composition for improving brain function for neonates
CN109789174B (zh) * 2016-05-31 2022-08-12 森永乳业株式会社 脑功能改善剂
RU2019105567A (ru) * 2016-07-28 2020-08-28 Фонтерра Ко-Оперэйтив Груп Лимитед Молочный продукт и способ
CN109963569A (zh) * 2016-10-05 2019-07-02 科尔生公司 用基于氨基酸的营养组合物喂养的婴儿或幼儿中肠道微生物群组成的正常化
EP3549593A4 (en) * 2016-11-29 2020-08-12 Morinaga Milk Industry Co., Ltd. PROMOTER OF AGLYCONE PRODUCTION
WO2018143793A1 (en) * 2017-02-01 2018-08-09 N.V. Nutricia Dietary modulation of brain functioning
EP3629769A1 (en) * 2017-05-24 2020-04-08 Société des Produits Nestlé S.A. Composition comprising human milk oligosaccharides (hmo) for use in the improvement of short term memory and other cognitive benefits
RU2019141902A (ru) * 2017-05-24 2021-06-17 Сосьете Де Продюи Нестле С.А. Композиция, содержащая олигофруктозу (of), для применения в улучшении кратковременной памяти и получении других когнитивных преимуществ
EP4159224A1 (en) * 2017-06-30 2023-04-05 N.V. Nutricia Synbiotic composition for preventing chronic inflammation
WO2019068356A1 (en) * 2017-10-06 2019-04-11 N.V. Nutricia PROMOTION OF COGNITIVE FUNCTIONS AFTER BIRTH OF CAESAREAN
CN111447936A (zh) * 2017-12-11 2020-07-24 N·V·努特里奇亚 用于治疗出生后双歧杆菌延迟定殖的组合物
US20210299193A1 (en) 2018-07-13 2021-09-30 Council Of Scientific & Industrial Research Synbiotic composition for improving immune response and antioxidant capacity during aging and a process for the preparation thereof
IT201900000043A1 (it) * 2019-01-03 2020-07-03 Watt S R L Sostituto della prima colazione
CN110214887B (zh) * 2019-06-28 2022-10-11 浙江大学 针对液体自冷型超高压杀菌的装置及方法
JP7406325B2 (ja) * 2019-08-08 2023-12-27 森永乳業株式会社 分離不安障害の予防又は改善のための組成物
GB2590624B (en) * 2019-12-20 2023-08-30 Green Bioactives Ltd Composition comprising one or more fructooligosaccharide(s) and L-theanine
EP3932415A1 (en) 2020-07-01 2022-01-05 Fundació Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI) Gut microbiota composition and uses thereof
CN113025677A (zh) * 2021-03-12 2021-06-25 长春大学 一种以海参为原料制备免消化海参蛋白质的方法
US20240358763A1 (en) * 2021-06-02 2024-10-31 N.V. Nutricia Supplement for human milk from allergic women
CN114533765B (zh) * 2022-03-17 2023-08-25 江南大学 短双歧杆菌ccfm1025在调节幼年神经发育中的应用
WO2024254188A2 (en) * 2023-06-05 2024-12-12 Infinant Health, Inc. Methods for treating enteric injury
GB2632345A (en) * 2023-08-03 2025-02-05 Mjn Us Holdings Llc Human milk fortifier micronutrient supplementation kit
WO2025027192A1 (en) * 2023-08-03 2025-02-06 Mjn U.S. Holdings Llc Human milk fortifier micronutrient supplementation kit
WO2025058081A1 (ja) * 2023-09-14 2025-03-20 江崎グリコ株式会社 総合注意力、認知柔軟性及び／又は実行機能を改善するための組成物
WO2025242902A1 (en) * 2024-05-24 2025-11-27 N.V. Nutricia Oligosaccharide mixture for brain development
WO2025257135A1 (en) * 2024-06-10 2025-12-18 N.V. Nutricia Non-digestible oligosaccharide mixture for infants at risk of brain injury

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070207132A1 (en) * 2003-10-24 2007-09-06 N.V. Nutricia Synbiotic Composition For Infants
WO2008111832A1 (en) * 2007-03-13 2008-09-18 N.V. Nutricia Method of improving skills with a composition comprising non-digestible saccharide
US20100278781A1 (en) * 2007-06-15 2010-11-04 Sander Hougee Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
US20120171165A1 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1065411C (zh) * 1995-06-18 2001-05-09 侯润安 新型保健营养奶粉及其生产方法
DE19961535A1 (de) 1999-12-20 2001-07-05 Vacuumschmelze Gmbh Filteranordnung
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
FR2853908B1 (fr) 2003-04-16 2005-06-03 Gervais Danone Sa Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
TR201820329T4 (tr) * 2005-02-28 2019-01-21 Nutricia Nv Probiyotik İçeren Besin Bileşimi
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
CN101795579A (zh) * 2006-08-04 2010-08-04 Shs国际有限公司 无蛋白配方
NL1033521C2 (nl) * 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
AU2008230747A1 (en) * 2007-03-27 2008-10-02 The Procter & Gamble Company Methods and kits for administering probiotics
EP2293677B1 (en) * 2008-06-13 2017-11-15 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
US20120195935A1 (en) 2009-07-27 2012-08-02 Virginia Commonwealth University Microbubble assisted viral delivery
EP2308498A1 (en) 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
US20110086809A1 (en) 2009-10-14 2011-04-14 Joshua Anthony Enteral Administration Of Arginine-Glutamine Dipeptide To Support Retinal, Intestinal, Or Nervous System Development
MY173944A (en) 2009-10-29 2020-02-28 Nestec Sa Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof
EP2335502A1 (en) * 2009-12-07 2011-06-22 Nestec S.A. An infant formula delivery system comprising probiotics and an infant nutritional formulation
US20110208153A1 (en) 2010-02-24 2011-08-25 John Alvey Formulations and methods for nutrient delivery
US20130095204A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions
RU2608232C2 (ru) 2012-01-09 2017-01-17 Н.В. Нютрисиа Обогащенная глутамином питательная композиция для недоношенных детей

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070207132A1 (en) * 2003-10-24 2007-09-06 N.V. Nutricia Synbiotic Composition For Infants
WO2008111832A1 (en) * 2007-03-13 2008-09-18 N.V. Nutricia Method of improving skills with a composition comprising non-digestible saccharide
US20100278781A1 (en) * 2007-06-15 2010-11-04 Sander Hougee Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
US20120171165A1 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria

Also Published As

Publication number Publication date
PH12015500904B1 (en) 2023-04-19
RU2015120800A (ru) 2016-12-27
IN2015DN03862A (enExample) 2015-10-02
BR112015009579B1 (pt) 2020-04-28
CN104883908A (zh) 2015-09-02
ES2884223T3 (es) 2021-12-10
RU2630905C2 (ru) 2017-09-14
EP2914136A2 (en) 2015-09-09
BR112015009579A2 (pt) 2017-07-04
PH12015500904A1 (en) 2015-07-13
PL2914136T3 (pl) 2021-11-29
WO2014070016A2 (en) 2014-05-08
US20150366919A1 (en) 2015-12-24
AU2013338705A2 (en) 2015-06-04
WO2014070016A3 (en) 2014-06-26
AU2013338705A1 (en) 2015-06-04
EP3936134A1 (en) 2022-01-12
CN107853705A (zh) 2018-03-30
US20190076490A1 (en) 2019-03-14
EP2914136B1 (en) 2021-05-26
US9974816B2 (en) 2018-05-22
MY173726A (en) 2020-02-18

Similar Documents

Publication Publication Date Title
AU2013338705B2 (en) Synbiotics combination for brain improvement
CN107019701B (zh) 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
Anderson et al. The role of intestinal barrier function in early life in the development of colitis
AU2018274636B2 (en) Composition comprising Human Milk Oligosaccharides (HMO) for use in the improvement of short term memory and other cognitive benefits
US12303522B2 (en) Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a gabaergic function in the central nervous system
AU2019296552B2 (en) Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a serotonergic function in the central nervous system
US20160136210A1 (en) Synbiotic composition for treatment of infections in allergic patients
JP2015503913A (ja) 認知機能の発達のためのラクトバチルス・ロイテリｄｓｍ１７９３８
CN104244736A (zh) 用于肠神经系统发育的罗伊氏乳杆菌dsm17938
RU2716214C2 (ru) Композиция для улучшения умственных способностей
RU2819351C2 (ru) Композиция, содержащая олигосахариды грудного молока, для применения в улучшении, усилении, стимулировании или модулировании серотонинергической функции в центральной нервной системе
US20240261346A1 (en) Nutritional composition for improving infant microbiota
RU2791622C2 (ru) Композиция, содержащая олигосахариды грудного молока (огм), для применения в улучшении кратковременной памяти и получении других когнитивных преимуществ

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 19 MAY 2015

FGA Letters patent sealed or granted (standard patent)